Genetic Signature in Selecting Adjuvant Treatment

Endocrine Therapy in Advanced Breast Cancer

Recent Consensus of Sentinel Lymph Node Biopsy

Tumor Microenvironment on Metastasis Research

Circulating Tumor Cell

PDX

Pros

Cons

[OP1-1] PROGNOSTIC VALUE OF TUMOR-TO-BREAST VOLUME RATIO VS. TUMOR SIZE REVISION OF TNM

[OP1-2] DOES INTERNAL MAMMARY NODE IRRADIATION AFFECT TREATMENT OUTCOME IN CLINICAL STAGE II-III BREAST CANCER PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY?

[OP1-3] TAU AND HER2 PREDICT PATHOLOGIC COMPLETE RESPONSE FOR ESTROGEN RECEPTOR-POSITIVE BREAST CANCER

[OP1-4] SURVIVAL OUTCOME OF CONCURRENT GnRH AGONIST PLUS TAMOXIFEN IS COMPARABLE TO THAT OF SEQUENTIAL ADRIAMYCIN AND CYCLOPHOSPHAMIDE CHEMOTHERAPY PLUS TAMOXIFEN IN PREMENOPAUSAL, LYMPH NODE-NEGATIVE, HORMONE-RESPONSIVE, HER2-NEGATIVE, T1-2 BREAST CANCER PATIENTS

[OP1-5] A PHASE II STUDY OF NEOADJUVANT CHEMOTHERAPY USING COMBINED TAXANE, ANTHRACYCLINE, AND CYCLOPHOSPHAMIDE IN HIGH RISK HER2-NEGATIVE LOCALLY ADVANCED BREAST CANCER

[OP1-6] PREDICTION OF THE BENEFIT OF RADIATION THERAPY AFTER BREAST-CONSERVING SURGERY IN ELDERLY BREAST CANCER PATIENTS: NOMOGRAM LEADS THE WAY

[OP1-7] EARLY CARDIAC TOXICITY WITH CONCURRENT TRASTUZUMAB AND LEFT-SIDED ADJUVANT RADIOTHERAPY

[OP1-8] NEOADJUVANT LETROZOLE AND LAPATINIB IN ASIAN POSTMENOPAUSAL WOMEN WITH ESTROGEN RECEPTOR AND HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-2 POSITIVE BREAST CANCER (NEO-ALL-IN): FIRST EFFICACY AND SAFETY REPORT

Radiation Therapy after NAC (Neoadjuvant Chemotherapy)

Surgical Issues

Response Evaluation

Pros

Cons

Medical Oncology

Surgical Oncology

Radiation Oncology